Report center

安信证券-血制品行业深度跟踪:年初至今批签发稳健增长,期待疫后常规需求持续回暖-230429

血制品行业深度跟踪:年初至今批签发 稳健增长,期待疫后常规需求持续回暖 目白蛋白:行业稳健增长,国产替代空间广阔。经测算,国内白蛋白的理论总年需求量为1500-1800吨,而我国白蛋白2022年批签发量约为667吨左右,市场渗透率为37%-44%,预计在患者基数增长与经济水平提高的驱动下市场规模将保持稳定增长。从批签发的情况看,进口人血白蛋白长期占据国内市场主导地位,国产白蛋白批签发批次占比虽在疫

No subject companies

Publishers

Suggested next hops

Ranked by edge type and evidence strength (max 5). Prefer these over scrolling the full lists.

  1. 1安信证券Published by or linked to this institution1
  2. 2Innovative Drugs & BiotechSame industry · 1 related reports1

Other hot industries

No related reports

← Back to knowledge graph